Mylan gets FDA warning letter over infractions at West Virginia plant
Mylan NV said on Tuesday it is addressing issues raised in a warning letter it received earlier this month from the U.S. Food and Drug Administration, which flagged concerns regarding the drugmaker's manufacturing plant in West Virginia. The company said the FDA's letter, dated Nov. 9, followed a regulatory inspection of its Morgantown, West Virginia plant in April. As a result of the company's ongoing restructuring at the facility, Mylan said there is a temporary disruption in supply of certain products and it has discontinued some ...
Click
To Read Full Article